Bryan Williams, co-chair of the 2018 ESC/ESH Hypertension Guidelines, lists the most important new recommendations. Furthermore, he comments on the discussion on differences between the European and American recommendations.
Learn more about the activities of EPCCS that are aimed at supporting primary care professionals manage their patients with cardiovascular and cardiometabolic disease.
Individuals without the 3 common shared risk factors hypertension, overweight and smoking had a delay of 9 years in the onset of disease and gain of 6 years in life expectancy compared to those with these 3 risk factors.
Neil Poulter stresses that, although high BP is considered a boring topic by some, it is crucial to be aware of it before it can be treated properly. You too can get involved in raising awareness.
In SPRINT MIND, no reduction was seen in probable dementia, after a median of 5 years of follow-up and 3.3 years of intervention, but mild cognitive impairment was reduced in the intensively treated arm.
In an analysis of the PARADIGM-HF and ATMOSPHERE trials with HFrEF patients, women showed lower rates of HF hospitalization and CV mortality, however, they had more symptoms and lower HRQL, and appeared undertreated, compared to men.
A network meta-analysis compared the SBP-lowering effectiveness of commonly prescribed antihypertensive treatments with structured exercise programs.
Prof. Hobbs stresses the importance of CVRM in primary care and how to manage this risk beyond glucose control.
Community-based data show that increasing categories of severity of hypertension according to the 2017 ACC/AHA BP Guidelines are associated with increasing risk of CVD events in middle age.
A small cross-sectional study showed an age-associated rise in BP starting in childhood in a more Westernized community, compared to an isolated, non-acculturated community.
In an observational study, antihypertensive treatment was not associated with reduced mortality or rates of CVD in low-risk patients with mild hypertension.
A retrospective study showed better SBP during antihypertensive therapy and lower risk of antihypertensive treatment failure in hypertensive patients with good oral health, as compared with those with periodontitis.